1.Surfactant replacement therapy in neonatal respiratory distress syndrome.
Chan Ok PARK ; Boung Yul LIM ; Byeong Gie YEO ; Ji Ho SONG ; Eun Kyung SOHN ; Chong Woo BAE ; Sa Jun CHUNG ; Chang Il AHN
Journal of the Korean Pediatric Society 1991;34(9):1211-1222
No abstract available.
Respiratory Distress Syndrome, Newborn*
2.Diagnostic accuracy of stable microbubble rating test for the early detection of neonatal respiratory distress syndrome.
Jung Sam JUN ; Chy Hyung PARK ; Jong Woo BAE ; Chang Il AHN
Journal of the Korean Pediatric Society 1992;35(10):1361-1368
No abstract available.
Microbubbles*
;
Respiratory Distress Syndrome, Newborn*
3.Perinatal Factors Influencing to the Response of Surfactant Replacement Therapy for the Neonatal Respiratory Distress Syndrome Patients.
Hye Jin KWON ; Seung Ah HONG ; Soon Woo KIM ; Yoon Jung CHO ; Sang Lak LEE ; Joon Sik KIM ; Tae Chan KWON
Korean Journal of Perinatology 2001;12(4):459-465
No abstract available.
Humans
;
Respiratory Distress Syndrome, Newborn*
4.Pulmonary Air Leak in the Neonatal Respiratory Distress Syndrome.
The Korean Journal of Thoracic and Cardiovascular Surgery 1999;32(1):38-42
BACKGROUND: In neonatal respiratory distress syndrome patients, various types of pulmonary air leak contributes to elevate morbity and mortality. Although early surgical interventions can provide better results in several cases, whole clinical outcomes are poor. This study was designed to investigate the clinical aspects of pulmonary air leak in the neonatal respiratory distress syndrome patients and major contributing factors to mortality. MATERIAL AND METHOD: We retrospectively evaluated 48 cases of pulmonary air leak in the neonatal respiratory distress syndrome patients from September 1994 to May 1997. RESULT: There were 15 cases of primary and 33 cases of secondary pulmonary air leakages. The prominent manifestations were pure interstitial emphysema in 19 cases(39.9%) and combined pneumothorax in 19 cases(39.9%). In clinical aspects, normal birth weight was dominant(83.4%), the onset occurred within 24 hours was in 28 cases(58.8%). The pulmonary diseases were meconium aspiration syndrome(25.2%) and hyaline membrane disease(33.2%). The overall hospital mortality was 25.2%, and the majority were hyaline membrane diseases. CONCLUSION: Although the overral mortality rate of these diseases were high, more detailed studies about immediate treatement, perinatal prevention, intensive care to geriatric problems were needed individually to improve outcomes.
Birth Weight
;
Emphysema
;
Hospital Mortality
;
Humans
;
Hyalin
;
Hyaline Membrane Disease
;
Infant, Newborn
;
Critical Care
;
Lung Diseases
;
Meconium Aspiration Syndrome
;
Membranes
;
Mortality
;
Pneumothorax
;
Respiratory Distress Syndrome, Newborn*
;
Retrospective Studies
5.The effect of antenatal betamethasone on prevent respiratory distress syndrome in premature infants
Journal Ho Chi Minh Medical 2004;8(1):39-47
A retrospective controlled cohort analysis of live-born singleton neonates prematurely born before 34 weeks’gestation was conducted in Tu Du Maternity Hospital in HCMC from January 2000 to December 2000. 217 premature infants were devided into 2 groups: group 1: 80 infants, whose mother taking prenatal betamethasone and group 2: 137 infants, whose mother without taking prenatal betamethasone. Data were analyzed with the T test, the Chi square test and Fisher exact test. Relative risk, 95% confident interval, other maternal and infant factors were calculated for betamethasone use. The results: the independent variables, which included maternal demographic, maternal clinical risk, infant characteristics were controlled. There were a significant statistical difference for Respiratory distress syndrome incidence of infants between 2 groups. Mean duration of ventilator and mean duration of neonatal hospital care were statistically different. All other short term side effects analyzed were similar between 2 groups
Respiratory Distress Syndrome, Newborn
;
Betamethasone
;
Infant, Premature
6.External laryngocoele: A rare cause of stridor in neonate
Nor Idayu M YUSOF ; Mohamamad Tamim JAMIL ; Irfan MOHAMAD
Brunei International Medical Journal 2012;8(1):43-47
A laryngocoele is an abnormal dilatation of the laryngeal saccule. It is a rare cause of stridor in the newborn or in early infancy. Most laryngocoeles are asymptomatic but symptoms of hoarseness, feeding difficulty, lump in the neck and upper airway obstruction may occur. We report a case of external laryngocoele causing partial airway obstruction in early infancy. Spontaneous resolution occurred following conservative medical management thus avoiding surgical intervention.
Infant
;
Complications
;
Respiratory Distress Syndrome, Newborn
7.The first evaluation of clinical efficacy of high-frequency oscillatory ventilation in the treatment of seriously respiratory distress syndrome in preterm babies at Tu Du hospital.
Xuan Minh Ngo ; Dung Van Nguyen
Journal of Medical Research 2007;55(6):65-71
Background:Pulmonary disease is still the main reason cause diseases and mortality for preterm babies. Objectives:This study aims to evaluate of the clinical efficacy of high-frequency oscillatory ventilation in the treatment of preterm infants who have seriously respiratory distress syndrome required mechanical ventilation. Subjects and method:A prospective clinical trail was conducted at Neonatal Unit of Tu Du Hospital from 1st December 2005 to 30th November 2006. Intervention: Patients were randomized to high-frequency oscillatory ventilation (20 patients) or conventional mechanical ventilation-CMV (59 patients). High-frequency oscillatory ventilation(HFOV) was used in high lung volume strategy. Results:The two groups of patients were similar in demographic distribution of birth weight, gestational age, gender, surfactant after birth. Patients on HFOV were ventilator \ufffd?dependent (2.14 \xb1 1.76 vs 3.48 \xb1 2.70 day. p=0.004) and respiratory pressure support (4.01 \xb1 2.23 vs 6.55 \xb1 day. p =0.02) for a shorter time than patients on CMV. Conclusion: First intention HFOV with high volume strategy shortened the time of ventilation and pressure support in preterm infants with seriously respiratory distress syndrome. In the future, it will be necessary to have the tremendous research for the efficacy of HFOV in order to decrease the ratio of bronchopulmonary dysplasia of infants who have seriously respiratory distress syndrome required mechanical ventilation.
Respiratory Distress Syndrome
;
Newborn/ therapy
;
Infant
;
Premature
8.Surfactant replacement therapy for prevention and treatment of respiratory distress syndrome of preterm infants
Ho Chi Minh city Medical Association 2005;10(3):132-134
During the period between 1999 and 2005, a clinical trial has been conducted at Hung Vuong Hospital to assess the efficacy of surfactant replacement therapy for prevention and treatment of respiratory distress syndrome (RDS) in preterm infants. Results: A total of 83 preterm infants with gestational age from 27 to 33 weeks were recruited, of whom 45 assigned to the prophylactic group and 38 to the rescue group. Percentages of developing or not reassuring RDS were 5.4% and 21.1% in the prophylactic and the rescue group, respectively (p<0.001). However, the difference in neonatal mortality was not statistically significant: 8.9% in the prophylactic in comparison with 15.8% in the rescue group
Respiratory Distress Syndrome, Adult
;
Respiratory Distress Syndrome
;
Newborn
;
Therapeutics
;
Pulmonary Surfactants
;
Prevention & control
;
Therapeutics
9.The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn.
Chinese Journal of Pediatrics 2015;53(2):104-108
OBJECTIVETo completely compare the risk factors, respiratory therapies and complications between respiratory distress syndrome (RDS) and transient tachypnea of newborn (TTN) in preterm infants.
METHODData were collected from preterm infants in Department of NICU, Peking University Third Hospital from January, 2013 to December, 2013. Components of clinical variables, including perinatal risk factors, ventilation therapies, pulmonary surfactant (PS) therapy, blood gas analysis and complications, were retrospectively analyzed. χ² test or Fisher's test or t test were used.
RESULTNinety-nine preterm infants mean gestational age was (31.9 ± 2.2) weeks and birth weight was (1 661 ± 501) g . Sixty-nine infants were diagnosed with TTN and 30 were diagnosed with RDS. There were significant differences in gestational age ((29.5 ± 2.5) vs. (32.0 ± 3.2) weeks, t = 6.046, P = 0.002), birth weight ((1 115 ± 415) vs. (1 660 ± 531) g, t = 5.916, P = 0.001). Nine cases in the RDS group had Apgar score ≤ 7 while four cases in the TTN group had Apgar score ≤ 7 (P = 0.001). Fourteen cases in RDS group were born through C-section while 55 cases of TTN group were born through C-section (P = 0.025). During 0-2 hours after birth, pH (7.25 ± 0.09 vs. 7.30 ± 0.01, t = -2.144, P = 0.046) was significantly lower in the RDS group. PaO₂((55 ± 20) vs. (41 ± 2) mmHg, 1 mmHg = 0.133 kPa, t = 2.963, P = 0.001) and oxigination index (OI) ((149 ± 58) vs.(100 ± 9) mmHg, t = 3.379, P = 0.003) were significantly lower in the TTN group. In the RDS group, all cases received PS therapy. Twenty-five cases received mechanical ventilation and five cases received noninvasive ventilation. In the TTN group, 12 cases received PS therapy. Forty-four cases received noninvasive ventilation and 25 cases received oxygen inhalation. The cases developing complications, including ventilator associated pneumonia (14(46.7%) vs.4(5.8%), P = 0.038), patent ductus arteriosus (19(63.3%) vs. 9(13.0%), P = 0.025), intraventricular hemorrhage (9(30.0%) vs. 2(2.9%), P = 0.041), bronchopulmonary dysplasia (12(40.0%) vs. 5(7.2%), P = 0.019), were significantly more in the RDS group.
CONCLUSIONRDS and TTN are common causes leading to early dyspnea in preterm infants. Preterm infants with RDS are characterized by younger gestational age, lower birth weight, severer acidosis and more complications. Preterm infants with TTN show lower hypoxemia and OI.
Apgar Score ; Birth Weight ; Blood Gas Analysis ; Bronchopulmonary Dysplasia ; Cesarean Section ; Ductus Arteriosus, Patent ; Female ; Gestational Age ; Humans ; Infant, Newborn ; Infant, Premature ; Pregnancy ; Pulmonary Surfactants ; Respiration, Artificial ; Respiratory Distress Syndrome, Newborn ; Retrospective Studies ; Risk Factors ; Transient Tachypnea of the Newborn